title: Effect of medical and surgical treatment of Barrett's metaplasia.
abstract: Barrett's esophagus (BE) is a change in the esophageal mucosa as a result of long-standing gastroesophageal reflux disease. The importance of BE is that it is the main risk factor for the development of esophageal adenocarcinoma, whose incidence is currently growing faster than any other cancer in the Western world. The aim of this review was to compare the common treatment modalities of BE, with the focus on proton pump inhibitors and operative fundoplication. We performed a literature search on medical and surgical treatment of BE to determine eligible studies for this review. Studies on medical and surgical treatment of BE are discussed with regard to treatment effect on progression and regression of disease. Although there is some evidence for control of reflux with either medical or surgical therapy, there is no definitive evidence that either treatment modality decreases the risk of progression to dysplasia or cancer. Even though there is a trend toward antireflux surgery being superior, there are no definitive studies to prove this.
authors.affiliation: Center for Videoendoscopic Surgery, Department of Surgery, University of Washington, Seattle, WA 98195, United States.
authors.forename: Eelco B
authors.initials: EB
authors.lastname: Wassenaar
authors.forename: Brant K
authors.initials: BK
authors.lastname: Oelschlager
mesh_terms: D001471:Barrett Esophagus / Q000473:pathology / Q000628:therapy*; D018450:Disease Progression; D004938:Esophageal Neoplasms / Q000473:pathology / Q000517:prevention & control*; D004947:Esophagus / Q000473:pathology / Q000601:surgery*; D018662:Fundoplication; D006801:Humans; D008679:Metaplasia; D011230:Precancerous Conditions / Q000473:pathology / Q000628:therapy*; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D054328:Proton Pump Inhibitors